Literature DB >> 21220309

Entry of diabetogenic T cells into islets induces changes that lead to amplification of the cellular response.

Boris Calderon1, Javier A Carrero, Mark J Miller, Emil R Unanue.   

Abstract

In an accompanying paper, we find specific localization of diabetogenic T cells only to islets of Langerhans bearing the specific antigen. Instrumental in the specific localization was the presence of intraislet dendritic cells bearing the β-cell-peptide-MHC complex. Here, we report that the entry of diabetogenic CD4 T cells very rapidly triggered inflammatory gene expression changes in islets and vessels by up-regulating chemokines and adhesion molecules. Vascular cell adhesion molecule-1 (VCAM-1) expression was notable in blood vessels, as was intercellular adhesion molecule-1 (ICAM-1). ICAM-1 was also found on β-cells. These expression changes induced the entry of nonspecific T cells that otherwise did not localize to the islets. In contrast to the entry of diabetogenic CD4 T cells, the entrance of nonspecific T cells required a chemokine response and VCAM-1 expression by the islets. IFN-γ was important for the early gene expression changes in the islets. By microarray analysis, we detected up-regulation of a group of IFN-inducible genes as early as 8 h post-T-cell transfer. These studies establish that entry of diabetogenic T cells induces a state of receptivity of islets to subsequent immunological insults.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21220309      PMCID: PMC3029718          DOI: 10.1073/pnas.1018975108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  Three or more routes for leukocyte migration into the central nervous system.

Authors:  Richard M Ransohoff; Pia Kivisäkk; Grahame Kidd
Journal:  Nat Rev Immunol       Date:  2003-07       Impact factor: 53.106

2.  T-lymphocyte entry into the central nervous system.

Authors:  W F Hickey; B L Hsu; H Kimura
Journal:  J Neurosci Res       Date:  1991-02       Impact factor: 4.164

3.  Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays.

Authors:  S D Der; A Zhou; B R Williams; R H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

4.  Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans.

Authors:  Boris Calderon; Javier A Carrero; Mark J Miller; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

5.  Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays.

Authors:  A K Cardozo; M Kruhøffer; R Leeman; T Orntoft; D L Eizirik
Journal:  Diabetes       Date:  2001-05       Impact factor: 9.461

Review 6.  IFN-inducible GTPases and immunity to intracellular pathogens.

Authors:  John D MacMicking
Journal:  Trends Immunol       Date:  2004-11       Impact factor: 16.687

7.  Progression to islet destruction in a cyclophosphamide-induced transgenic model: a microarray overview.

Authors:  Michael Matos; Richard Park; Diane Mathis; Christophe Benoist
Journal:  Diabetes       Date:  2004-09       Impact factor: 9.461

8.  A giant GTPase, very large inducible GTPase-1, is inducible by IFNs.

Authors:  Thorsten Klamp; Ulrich Boehm; Daniela Schenk; Klaus Pfeffer; Jonathan C Howard
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

9.  Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords.

Authors:  J G Cyster; C C Goodnow
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

10.  Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma.

Authors:  J L Baron; J A Madri; N H Ruddle; G Hashim; C A Janeway
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

View more
  38 in total

1.  Functional specialization of islet dendritic cell subsets.

Authors:  Na Yin; Jiangnan Xu; Florent Ginhoux; Gwendalyn J Randolph; Miriam Merad; Yaozhong Ding; Jonathan S Bromberg
Journal:  J Immunol       Date:  2012-04-16       Impact factor: 5.422

2.  Metagenomics and personalized medicine.

Authors:  Herbert W Virgin; John A Todd
Journal:  Cell       Date:  2011-09-30       Impact factor: 41.582

Review 3.  Immune cell trafficking to the islets during type 1 diabetes.

Authors:  A M Sandor; J Jacobelli; R S Friedman
Journal:  Clin Exp Immunol       Date:  2019-08-30       Impact factor: 4.330

4.  Anti-coreceptor therapy drives selective T cell egress by suppressing inflammation-dependent chemotactic cues.

Authors:  Aaron J Martin; Matthew Clark; Gregory Gojanovich; Fatima Manzoor; Keith Miller; Douglas E Kline; Y Maurice Morillon; Bo Wang; Roland Tisch
Journal:  JCI Insight       Date:  2016-10-20

5.  Transplant rejection and paradigms lost.

Authors:  Terry B Strom
Journal:  J Clin Invest       Date:  2013-05-15       Impact factor: 14.808

6.  Cognate antigen directs CD8+ T cell migration to vascularized transplants.

Authors:  Jeffrey M Walch; Qiang Zeng; Qi Li; Martin H Oberbarnscheidt; Rosemary A Hoffman; Amanda L Williams; David M Rothstein; Warren D Shlomchik; Jiyun V Kim; Geoffrey Camirand; Fadi G Lakkis
Journal:  J Clin Invest       Date:  2013-05-15       Impact factor: 14.808

Review 7.  Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease.

Authors:  Kate L Graham; Robyn M Sutherland; Stuart I Mannering; Yuxing Zhao; Jonathan Chee; Balasubramanian Krishnamurthy; Helen E Thomas; Andrew M Lew; Thomas W H Kay
Journal:  Rev Diabet Stud       Date:  2012-12-28

8.  An evolving autoimmune microenvironment regulates the quality of effector T cell restimulation and function.

Authors:  Rachel S Friedman; Robin S Lindsay; Jason K Lilly; Vinh Nguyen; Caitlin M Sorensen; Jordan Jacobelli; Matthew F Krummel
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-10       Impact factor: 11.205

Review 9.  The central role of antigen presentation in islets of Langerhans in autoimmune diabetes.

Authors:  Boris Calderon; Javier A Carrero; Emil R Unanue
Journal:  Curr Opin Immunol       Date:  2013-11-16       Impact factor: 7.486

Review 10.  Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.

Authors:  Nadir Askenasy
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.